Sectors
CALC
CalciMedica, Inc.
2.14
1 x 0.65
1 x 0.59
bid
ask
-
0.18
7.84%
1 @ 04:13 PM
2.22 +0.08 (3.70%)
| Ytd | -67.53% | |
| 1y | -20.74% |
2.13
day range
2.47
2.13
52 week range
36.00
| Open | 2.30 | Prev Close | 2.32 | Low | 2.13 | High | 2.47 | Mkt Cap | 14.61M |
| Vol | 165.07K | Avg Vol | 272.02K | EPS | -6.85 | P/E | N/A | Forward P/E | -1.69 |
| Beta | 0.91 | Short Ratio | 1.68 | Inst. Own | 43.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 3.74 | 200-d Avg | 8.87 | 1yr Est | 17.00 |
| Income Statement | |||
| Operating Expenses | 4.01M | ||
| Research and Development Expense | 2.10M | ||
| Selling, General and Administrative Expense | 1.91M | ||
| Operating Income | -4.01M | ||
| Interest Expense | 325.00K | ||
| Net Income | -7.65M | ||
| Net Income Common Stock | -7.65M | ||
| Net Income Common Stock (USD) | -7.65M | ||
| Consolidated Income | -7.65M | ||
| Earnings per Basic Share | -0.45 | ||
| Earnings per Basic Share (USD) | -0.45 | ||
| Earnings per Diluted Share | -0.45 | ||
| Earning Before Interest & Taxes (EBIT) | -7.33M | ||
| Earning Before Interest & Taxes (USD) | -7.33M | ||
| Weighted Average Shares | 17.10M | ||
| Weighted Average Shares Diluted | 17.10M | ||
| Balance Sheet | |||
| Cash and Equivalents | 18.62M | ||
| Cash and Equivalents (USD) | 18.62M | ||
| Current Assets | 19.46M | ||
| Property, Plant & Equipment Net | 36.00K | ||
| Total Assets | 19.50M | ||
| Total Debt | 9.20M | ||
| Current Liabilities | 3.49M | ||
| Debt Non-Current | 9.20M | ||
| Total Liabilities | 13.99M | ||
| Accumulated Retained Earnings (Deficit) | -192.00M | ||
| Accumulated Other Comprehensive Income | -1000 | ||
| Shareholders Equity | 5.51M | ||
| Shareholders Equity (USD) | 5.51M | ||
| Assets Non-Current | 40.00K | ||
| Total Debt (USD) | 9.20M | ||
| Liabilities Non-Current | 10.50M | ||
| Trade and Non-Trade Payables | 2.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 7.00K | ||
| Net Cash Flow from Financing | 15.03M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 10.45M | ||
| Capital Expenditure | 42.00K | ||
| Issuance (Purchase) of Equity Shares | 12.03M | ||
| Net Cash Flow from Investing | 42.00K | ||
| Net Cash Flow from Operations | -4.62M | ||
| Share Based Compensation | 540.00K | ||